ARKG Holding Accolade Up 60% in Past Month

The ARK Genomic Revolution ETF (ARKG) has increased over 5.5% by mid-day Thursday as biotech continues to rally and broader markets increase. The fund is up 18.08% over the past five days and 13.7% over the past month, partially recouping losses from earlier in the year. The fund is down 40.96%...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.